The Year in Cardiology 2013: cardiovascular disease prevention
The Year in Cardiology 2013: cardiovascular disease prevention
复制标题
DOI：
10.1093/eurheartj/eht551
复制
发表时间：
2014-02-01
影响因子：
39.3
通讯作者：
Landmesser, U.
中科院分区：
文献类型：
--
作者：
Gielen, S.;Landmesser, U.
过去三十年来，欧洲心血管死亡率下降了近 50%，这主要归功于危险因素控制和预防干预措施的改善以及治疗的改善。本综述概述了 2013 年发表的流行病学、高血压控制、血脂学、糖尿病学和生活方式改变方面的关键研究。糖尿病学中的 EXAMINE 以及血脂学中的 AIM-High 和 HPS-2-THRIVE 未能证明事件减少。根据EUROASPIRE IV，二级预防治疗的临床实施仍然不够理想。 2013年预防方面的研究亮点证明了该领域知识的动态进步；然而，如果不实施，光有知识是徒劳的。
The decline in cardiovascular mortality in Europe by nearly 50% over the last three decades resulted in particular from improved risk factor control and prevention interventions in addition to improved treatment. This review provides an overview of key studies in epidemiology, hypertension control, lipidology, diabetology, and lifestyle changes published in 2013. EXAMINE in diabetology and AIM-High and HPS-2-THRIVE in lipidology failed to demonstrate an event reduction. According to EUROASPIRE IV clinical implementation of secondary prevention treatments is still suboptimal. The 2013 study highlights in prevention prove the dynamic progress of knowledge in the field;, however, knowledge alone is futile without implementation.